NCT02229955View on ClinicalTrials.gov

Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 31, 2013

Primary Completion Date

April 30, 2014

Study Completion Date

July 31, 2014

Conditions

Dry Eye Syndromes

Interventions

DRUG

Cyclosporine ophthalmic solution

1 drop twice/day for 12 weeks to both eyes

Trial Locations (1)

137-701

The catholic university of Korea seoul st. Mary's hospital, Seoul

All Listed Sponsors

lead

Hanlim Pharm. Co., Ltd.

INDUSTRY

NCT02229955 - Study of Tisporin Eye Drops Group and Restasis Eye Drops Group After Treatment, Each Treatment Group Comparisons for Evaluation of Efficacy and Safety in Moderate to Severe Dry Eye Disease | Biotech Hunter | Biotech Hunter